CLASS I Drug recall · Reported 26 Aug 2020 · FDA Enforcement Report
Ddavp Nasal Spray (desmopressin acetate) 10 mcg recalled
Ferring Pharmaceuticals is recalling Ddavp Nasal Spray (desmopressin acetate) 10 mcg, distributed nationwide in the US. The recall was initiated on 21 Jul 2020 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1504-2020
- FDA event ID
- 86066
- Recalling firm
- Ferring Pharmaceuticals, Parsippany, NJ
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 21 Jul 2020
- FDA classified
- 17 Aug 2020
- Reported
- 26 Aug 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Nasal Sprays
Timeline
| 21 Jul 2020 | Recall initiated by company | |
| 17 Aug 2020 | Classified by FDA | +27 days |
| 26 Aug 2020 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Superpotent Drug
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0
Where it was distributed
Nationwide within the United States.
Questions about this recall
Why was it recalled?
Superpotent Drug
Which lots are affected?
Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022
Where was it sold?
Nationwide within the United States.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
2 other products · FDA event 86066This product is part of a recall event; the main page for the event is Stimate (desmopressin acetate) Nasal Spray1.5 mg/mL glass recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS I | Stimate (desmopressin acetate) Nasal Spray1.5 mg/mL glass recalled | Ferring Pharmaceuticals | Potency & Assay | Nationwide | |
| CLASS I | Desmopressin Acetate Nasal Spray 10 mcg/ glass vial with spray cap recalled | Ferring Pharmaceuticals | Potency & Assay | Nationwide |
More recalls from Ferring Pharmaceuticals
All 12| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Endometrin (progesterone) Vaginal Insert 100mg recalled | Ferring Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Zoma-Jet 5 Demonstration Kit recalled by Ferring Pharmaceuticals | Ferring Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Zoma-Jet 10 Demonstration Kit recalled by Ferring Pharmaceuticals | Ferring Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Menopur 75 IU, (menotropins for injection) recalledMenopur | Ferring Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS I | Desmopressin Acetate Nasal Spray 10 mcg/ glass vial with spray cap recalled | Ferring Pharmaceuticals | Potency & Assay | Nationwide |